OXCT1 and breast cancer: In further support of this “metabolic-coupling” hypothesis, recombinant over-expression of ACAT1 or OXCT1 in MDA-MB-231 breast cancer cells was indeed sufficient to promote tumor growth and lung metastasis [4].